Radiomics signature for dynamic monitoring of tumor inflamed microenvironment and immunotherapy response prediction

Radiomics signature for dynamic monitoring of tumor inflamed microenvironment and immunotherapy response prediction

Background The efficacy of immune checkpoint inhibitors (ICIs) depends on the tumor immune microenvironment (TIME), with a preference for a T cell-inflamed TIME. However, challenges in tissue-based assessments via biopsies have triggered the exploration of non-invasive alternatives, such as radiomic...

Full description

Bibliographic Details
Main Authors: Enriqueta Felip, Paolo Nuciforo, Elena Garralda, Joan Frigola, Ramon Amat, Garazi Serna, Francesco Grussu, Kinga Bernatowicz, Olivia Prior, Marta Ligero, Christina Zatse, Rodrigo Toledo, Manel Escobar, Raquel Perez-Lopez
Format: Article
Language:English
Published: BMJ Publishing Group 2025-01-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/13/1/e009140.full

Internet

https://jitc.bmj.com/content/13/1/e009140.full

Similar Items